![Lauren Tyra](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lauren Tyra
Direktor/Vorstandsmitglied bei Gregor Diagnostics, Inc.
Profil
Lauren Tyra is currently the Director at Gregor Diagnostics, Inc. and the Chief Scientific Officer at Green Park & Golf Ventures LLC.
She completed her undergraduate degree at the University of North Texas and her doctorate degree at The University of Texas Southwestern Medical Center in 2017.
Aktive Positionen von Lauren Tyra
Unternehmen | Position | Beginn |
---|---|---|
Green Park & Golf Ventures LLC
![]() Green Park & Golf Ventures LLC Investment ManagersFinance Green Park & Golf Ventures LLC (Green Park & Golf Ventures) is a venture capital firm founded in 2011. The firm is headquartered in Dallas, Texas. | Corporate Officer/Principal | 01.03.2020 |
Gregor Diagnostics, Inc.
![]() Gregor Diagnostics, Inc. Medical SpecialtiesHealth Technology Gregor Diagnostics, Inc. develops and manufactures molecular diagnostics screening tests for prostate cancer. It provides proprietary system to maintain biomarker stability in the seminal fluid. The company was founded by Tobias Zutz in February 2016 and is headquartered in Madison, WI. | Direktor/Vorstandsmitglied | - |
Ausbildung von Lauren Tyra
University of North Texas | Undergraduate Degree |
The University of Texas Southwestern Medical Center | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Green Park & Golf Ventures LLC
![]() Green Park & Golf Ventures LLC Investment ManagersFinance Green Park & Golf Ventures LLC (Green Park & Golf Ventures) is a venture capital firm founded in 2011. The firm is headquartered in Dallas, Texas. | Finance |
Gregor Diagnostics, Inc.
![]() Gregor Diagnostics, Inc. Medical SpecialtiesHealth Technology Gregor Diagnostics, Inc. develops and manufactures molecular diagnostics screening tests for prostate cancer. It provides proprietary system to maintain biomarker stability in the seminal fluid. The company was founded by Tobias Zutz in February 2016 and is headquartered in Madison, WI. | Health Technology |